Respiratory Infections Clinical Trial
— IMPAACTOfficial title:
Improving Antibiotic Use in Acute Care Setting
Verified date | April 2015 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
Purpose The emergence and rapid rise in antibiotic resistance among common bacteria are adversely affecting the clinical course and health care costs of community-acquired infections. Because antibiotic resistance rates are strongly correlated with antibiotic use patterns, multiple organizations have declared reductions in unnecessary antibiotic use to be critical components of efforts to combat antibiotic resistance. Among humans, the vast majority of unnecessary antibiotic prescriptions are used to treat acute respiratory tract infections (ARIs) that have a viral etiology. Although the rate of antibiotic prescribing for ARIs by office-based physicians in the US has decreased about 16% from its peak in 1997, the rate of antibiotic prescribing in acute care settings (eg, emergency departments and urgent care centers), which account for 1 in 5 ambulatory antibiotic prescriptions in the US, has shown only a modest decline (6%) during this period. Translation of lessons from intervention studies in office-based practices is needed to improve antibiotic use in acute care settings.
Status | Completed |
Enrollment | 1000 |
Est. completion date | July 2007 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Emergency room patient - Selected VA or Non-VA patients - Age 18 years or older - Patient must have acute respiratory illness - Patient must not have been seen in Emergency Department within 4 weeks Exclusion Criteria: - Patients less than 18 years of age - Patient in Emergency Department for non-acute respiratory infection |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
United States | New Mexico VA Health Care System, Albuquerque, NM | Albuquerque | New Mexico |
United States | Charlie Norwood VA Medical Center, Augusta, GA | Augusta | Georgia |
United States | James J. Peters VA Medical Center, Bronx, NY | Bronx | New York |
United States | Edward Hines Jr. VA Hospital, Hines, IL | Hines | Illinois |
United States | Kansas City VA Medical Center, Kansas City, MO | Kansas City | Missouri |
United States | Philadelphia VA Medical Center, Philadelphia, PA | Philadelphia | Pennsylvania |
United States | VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Pittsburgh | Pennsylvania |
United States | South Texas Health Care System, San Antonio, TX | San Antonio | Texas |
United States | VA San Diego Healthcare System, San Diego, CA | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development | Agency for Healthcare Research and Quality (AHRQ) |
United States,
Aspinall SL, Metlay JP, Maselli JH, Gonzales R. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments. Am J Manag Care. 2007 May;13(5):241-8. — View Citation
Gonzales R, Camargo CA Jr, MacKenzie T, Kersey AS, Maselli J, Levin SK, McCulloch CE, Metlay JP; IMPAACT Trial Investigators. Antibiotic treatment of acute respiratory infections in acute care settings. Acad Emerg Med. 2006 Mar;13(3):288-94. — View Citation
Metlay JP, Camargo CA Jr, Bos K, Gonzales R. Assessing the suitability of intervention sites for quality improvement studies in emergency departments. Acad Emerg Med. 2005 Jul;12(7):667-70. — View Citation
Metlay JP, Camargo CA Jr, MacKenzie T, McCulloch C, Maselli J, Levin SK, Kersey A, Gonzales R; IMPAACT Investigators. Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments. Ann Eme — View Citation
Nolt BR, Gonzales R, Maselli J, Aagaard E, Camargo CA Jr, Metlay JP. Vital-sign abnormalities as predictors of pneumonia in adults with acute cough illness. Am J Emerg Med. 2007 Jul;25(6):631-6. — View Citation
Pines JM, Hollander JE, Lee H, Everett WW, Uscher-Pines L, Metlay JP. Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia. Acad Emerg Med. 2007 Jun;14(6):545-8. Epub 2007 Apr 30. — View Citation
Vanderweil SG, Pelletier AJ, Hamedani AG, Gonzales R, Metlay JP, Camargo CA Jr. Declining antibiotic prescriptions for upper respiratory infections, 1993-2004. Acad Emerg Med. 2007 Apr;14(4):366-9. Epub 2007 Feb 12. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of all acute respiratory infection visits treated with antibiotics | No | ||
Secondary | Delayed antibiotic treatment of acute respiratory infections; Patient satisfaction | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00369759 -
An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants
|
N/A | |
Completed |
NCT01907659 -
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
|
N/A | |
Completed |
NCT00388921 -
High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM
|
N/A | |
Completed |
NCT02211729 -
A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children
|
Phase 3 | |
Recruiting |
NCT03093220 -
Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis
|
N/A | |
Recruiting |
NCT01167686 -
Effects of Gardemont S.A Food Supplement on Upper Respiratory Illness
|
Phase 2 | |
Completed |
NCT00514670 -
A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program
|
N/A | |
Completed |
NCT02927743 -
Effect of Evidence-based Reminders on Use of Antibiotics
|
N/A | |
Completed |
NCT02438293 -
'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
|
||
Completed |
NCT04362059 -
A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19
|
N/A | |
Completed |
NCT00533182 -
Influenza in People With Normal and Weakened Immune Systems
|
||
Completed |
NCT01909128 -
Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms
|
Phase 3 | |
Recruiting |
NCT05474430 -
Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
|
||
Completed |
NCT01443728 -
Vitamin D for Sickle-cell Respiratory Complications
|
Phase 2 | |
Completed |
NCT02491164 -
Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe
|
Early Phase 1 | |
Completed |
NCT01390753 -
Role of Human Milk Bank in the Protection of Severe Respiratory Disease in Very Low Birth Weight Premature Infants
|
N/A |